PRQR icon

ProQR Therapeutics

55 hedge funds and large institutions have $47.5M invested in ProQR Therapeutics in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

21% less capital invested

Capital invested by funds: $60M → $47.5M (-$12.4M)

26% less call options, than puts

Call options by funds: $705K | Put options by funds: $950K

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$705K
Puts
$950K
Net Calls
Net Calls Change

Top Buyers

1 +$6.18M
2 +$2.39M
3 +$2M
4
Morgan Stanley
Morgan Stanley
New York
+$576K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$470K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$11.4M
2
$7.72M
3
$6.18M
4
$4.07M
5
$2.79M
6
$2M
7
$1.39M
8
$1.38M
9
$1.34M
10
$1.32M
11
$1.01M
12
$890K
13
$820K
14
$797K
15
$474K
16
$383K
17
$382K
18
$364K
19
$326K
20
$320K
21
$215K
22
$213K
23
$204K
24
$201K
25
$189K